Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| goblet cell | 5 studies | 18% ± 3% | |
| epithelial cell | 5 studies | 28% ± 13% | |
| enterocyte | 4 studies | 21% ± 3% | |
| ciliated cell | 3 studies | 23% ± 3% | |
| secretory cell | 3 studies | 19% ± 1% | |
| basal cell | 3 studies | 21% ± 4% |
Insufficient scRNA-seq data for expression of VILL at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| intestine | 100% | 3307.89 | 965 / 966 | 97% | 33.83 | 513 / 527 |
| stomach | 100% | 3993.30 | 358 / 359 | 97% | 27.55 | 276 / 286 |
| thymus | 100% | 1207.76 | 653 / 653 | 91% | 8.53 | 551 / 605 |
| skin | 100% | 855.08 | 1804 / 1809 | 85% | 5.86 | 401 / 472 |
| uterus | 100% | 1112.41 | 170 / 170 | 81% | 13.93 | 372 / 459 |
| prostate | 100% | 2263.21 | 245 / 245 | 79% | 7.94 | 398 / 502 |
| bladder | 100% | 2116.62 | 21 / 21 | 79% | 19.52 | 396 / 504 |
| ovary | 100% | 974.98 | 180 / 180 | 75% | 6.72 | 322 / 430 |
| lung | 99% | 964.07 | 575 / 578 | 72% | 11.12 | 828 / 1155 |
| breast | 100% | 1017.69 | 459 / 459 | 68% | 4.66 | 761 / 1118 |
| kidney | 99% | 642.07 | 88 / 89 | 65% | 3.68 | 589 / 901 |
| adrenal gland | 99% | 513.25 | 255 / 258 | 63% | 4.98 | 145 / 230 |
| esophagus | 100% | 663.09 | 1439 / 1445 | 61% | 16.98 | 111 / 183 |
| pancreas | 65% | 193.60 | 213 / 328 | 93% | 68.33 | 165 / 178 |
| brain | 99% | 819.79 | 2614 / 2642 | 54% | 3.50 | 381 / 705 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 10.29 | 29 / 29 |
| spleen | 100% | 1770.66 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.30 | 1 / 1 |
| adipose | 100% | 795.45 | 1201 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 98% | 859.17 | 912 / 929 | 0% | 0 | 0 / 0 |
| blood vessel | 98% | 510.61 | 1308 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 95% | 6.59 | 76 / 80 |
| heart | 90% | 451.93 | 779 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 69% | 5.98 | 31 / 45 |
| liver | 15% | 34.00 | 34 / 226 | 7% | 1.18 | 30 / 406 |
| muscle | 16% | 36.69 | 127 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0051014 | Biological process | actin filament severing |
| GO_0051016 | Biological process | barbed-end actin filament capping |
| GO_0008154 | Biological process | actin polymerization or depolymerization |
| GO_0015629 | Cellular component | actin cytoskeleton |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005200 | Molecular function | structural constituent of cytoskeleton |
| GO_0005546 | Molecular function | phosphatidylinositol-4,5-bisphosphate binding |
| GO_0051015 | Molecular function | actin filament binding |
| Gene name | VILL |
| Protein name | Villin-like isoform 1 Villin-like protein Villin like Villin-like isoform 2 |
| Synonyms | |
| Description | FUNCTION: Possible tumor suppressor. |
| Accessions | ENST00000492491.6 H7BZ43 A0A0S2Z5H2 ENST00000383759.7 [O15195-1] O15195 ENST00000283713.10 [O15195-1] ENST00000465644.5 E9PFV5 D6R9H2 A0A0S2Z5G7 ENST00000412008.5 |
